论文部分内容阅读
目的探讨微创胸腔置管引流并尿激酶胸腔内注射治疗结核性包裹性胸膜炎的方法及临床效果。方法在常规药物治疗基础上行微创胸腔置管引流及尿激酶胸腔内注射(引流注药组),并与反复胸腔穿刺抽液方法(常规治疗组)进行综合比较。结果引流注药组可显著增加胸水引流量,减少胸膜肥厚,症状消失快,并发症少,住院时间短,其效果优于常规治疗组。结论微创胸腔置管引流并尿激酶胸腔内注射是一项安全有效、创伤小、易实施,是包裹性结核性胸膜炎的首选治疗方案。
Objective To investigate the methods and clinical effects of minimally invasive thoracic drainage and urokinase intrathoracic injection for the treatment of tuberculous pleurisy. Methods The minimally invasive thoracic catheter drainage and urokinase intrathoracic injection (drainage injection group) were performed on the basis of conventional drug therapy, and were compared with repeated thoracentesis and drainage method (conventional treatment group). Results Drainage injection group can significantly increase pleural effusion volume, reduce pleural thickening, rapid disappearance of symptoms, fewer complications, shorter hospital stay, the effect is better than the conventional treatment group. Conclusion Minimally invasive thoracic drainage and urokinase thoracic injection is a safe and effective, less invasive and easy to implement, and is the first choice of treatment for tuberculous pleurisy.